These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8476968)

  • 1. The role of aerosol pentamidine prophylaxis.
    Ong EL
    Int J STD AIDS; 1993; 4(2):67-9. PubMed ID: 8476968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of intravenous pentamidine prophylaxis for Pneumocystis carinii pneumonia.
    Weintrub PS; Wara DW; Duliege AM
    J Pediatr; 1993 Jan; 122(1):163-4. PubMed ID: 8419606
    [No Abstract]   [Full Text] [Related]  

  • 3. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.
    Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC
    N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus.
    MMWR Recomm Rep; 1992 Apr; 41(RR-4):1-11. PubMed ID: 1348843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.
    Hardy WD; Feinberg J; Finkelstein DM; Power ME; He W; Kaczka C; Frame PT; Holmes M; Waskin H; Fass RJ
    N Engl J Med; 1992 Dec; 327(26):1842-8. PubMed ID: 1448121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosolized pentamidine prophylaxis of Pneumocystis carinii pneumonia.
    Wilkinson SB
    Am J Med; 1995 Apr; 98(4):422-3. PubMed ID: 7709963
    [No Abstract]   [Full Text] [Related]  

  • 8. High dose aerosol pentamidine for secondary Pneumocystis carinii pneumonia prophylaxis in AIDS patients.
    Flamholc L; Haidl S; Westin E; Borgdalen L; Prellner T
    Infection; 1992; 20(6):309-12. PubMed ID: 1293048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies Infectieuses.
    May T; Beuscart C; Reynes J; Marchou B; Leclercq P; Borsa Lebas F; Saba J; Micoud M; Mouton Y; Canton P
    J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):457-62. PubMed ID: 8158539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.
    Carr A; Tindall B; Penny R; Cooper DA
    AIDS; 1992 Feb; 6(2):165-71. PubMed ID: 1558714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An effectiveness community-based clinical trial of Respirgard II and Fisoneb nebulizers for Pneumocystis carinii prophylaxis with aerosol pentamidine in HIV-infected individuals. Toronto Aerosol Pentamidine Study (TAPS) Group.
    McIvor RA; Berger P; Pack LL; Rachlis A; Chan CK
    Chest; 1996 Jul; 110(1):141-6. PubMed ID: 8681618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
    Kitazawa T; Seo K; Yoshino Y; Asako K; Kikuchi H; Kono H; Ota Y
    J Infect Chemother; 2019 May; 25(5):351-354. PubMed ID: 30711257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
    Bozzette SA; Finkelstein DM; Spector SA; Frame P; Powderly WG; He W; Phillips L; Craven D; van der Horst C; Feinberg J
    N Engl J Med; 1995 Mar; 332(11):693-9. PubMed ID: 7854375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized study of sulfamethoxazole-trimethoprim versus aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS.
    Nielsen TL; Jensen BN; Nelsing S; Mathiesen LR; Skinhøj P; Nielsen JO
    Scand J Infect Dis; 1995; 27(3):217-20. PubMed ID: 8539544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
    Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
    JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial. The Italian PCP Study Group.
    Rizzardi GP; Lazzarin A; Musicco M; Frigerio D; Maillard M; Lucchini M; Moroni M
    J Infect; 1996 Mar; 32(2):123-31. PubMed ID: 8708369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular pentamidine for the prevention of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus.
    Cheung TW; Matta R; Neibart E; Hammer G; Chusid E; Sacks HS; Szabo S; Rose D
    Clin Infect Dis; 1993 Jan; 16(1):22-5. PubMed ID: 8448314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Torres RA; Barr M; Thorn M; Gregory G; Kiely S; Chanin E; Carlo C; Martin M; Thornton J
    Am J Med; 1993 Dec; 95(6):573-83. PubMed ID: 8018144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerosolized pentamidine as primary prophylaxis for Pneumocystis carinii pneumonia: efficacy, mortality and morbidity.
    Lidman C; Berglund O; Tynell E; Lindbäck S; Elvin K
    AIDS; 1994 Jul; 8(7):935-9. PubMed ID: 7946102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost and benefit of secondary prophylaxis for Pneumocystis carinii pneumonia.
    Castellano AR; Nettleman MD
    JAMA; 1991 Aug; 266(6):820-4. PubMed ID: 1907671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.